NCT00395135View on ClinicalTrials.gov

BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

PHASE3CompletedINTERVENTIONAL
Enrollment

3,182

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Obesity
Interventions
DRUG

Lorcaserin 10 mg BID

Lorcaserin 10 mg tablet each morning and evening for a duration of 52 or 104 weeks.

DRUG

Matching Placebo BID

Matching placebo tablet each morning and evening for a duration of 52 or 104 weeks.

Trial Locations (1)

92121

Arena Pharmaceuticals, Inc., San Diego

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00395135 - BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management | Biotech Hunter | Biotech Hunter